Phenylketonuria Pku : Food Controlled Genetic Disease
Abstract
Keywords
References
- Dokoupil K, Gokmen-Ozel H, Lammardo AM, Motzfeldt K, Robert M, Rocha JC, van Rijn M, Ahring K, Bélanger-Quintana A, MacDonald A., “Optimising growth in phenylketonuria: current state of the clinical evidence base.”, Clin Nutr. vol. 31, pp.16-21, 2012.
- Bélanger-Quintana A, Burlina A, Harding CO, Muntau AC, “Up to date knowledge on different treatment strategies for phenylketonuria.”, Mol Genet Metab. Vol 104 Suppl:S, pp. 19-25, 2011.
- Belanger-Quintana A, Dokoupil K, Gokmen-Ozel H, Lammardo AM, MacDonald A, Motzfeldt K, Nowacka M, Robert M, van Rijn M, Ahring K. “Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers.”, Mol Genet Metab.,vol 105, pp 390-4, 2012
- Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, et al. Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol Genet Metab. vol 112, pp 87-122, 2014.
- Pimentel FB, Alves RC, Costa AS, Torres D, Almeida MF, Oliveira MB, “Phenylketonuria: protein content and amino acids profile of dishes for phenylketonuric patients. The relevance of phenylalanine.”, Food Chem. vol 149, pp.144-50, 2014. [6] Demirkol M, Giżewska M, Giovannini M, Walter J, “Follow up of phenylketonuriapatients.”, Mol Genet Metab., vol 104 Suppl:S, pp 31-9, 2011.
- Rocha JC, Martel F, “Large neutral amino acids supplementation
- inphenylketonuric patients.”, J Inherit Metab Dis. vol 32, pp. 472-80, 2009.
- Blau N, van Spronsen FJ, Levy HL, “Phenylketonuria”, Lancet, vol 376, pp.1417-27, 2010. [9] Feillet F, Agostoni C, “Nutritional issues in treating phenylketonuria”, J Inherit Metab Dis., vol 33, pp. 659-64, 2010.
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Mine Ergüven
This is me
Publication Date
June 1, 2015
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2015 Volume: 1 Number: 1
